figshare
Browse
12933_2024_2155_MOESM1_ESM.docx (116.87 kB)

Additional file 1 of Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials

Download (116.87 kB)
journal contribution
posted on 2024-02-16, 04:41 authored by Young Sang Lyu, Sangmo Hong, Si Eun Lee, Bo Young Cho, Cheol-Young Park
Supplementary Material 1

Funding

Daewoong Pharmaceutical Company

History

Usage metrics

    Cardiovascular Diabetology

    Categories

    Keywords

    EnavogliflozinGlycemic controlNon-insulin dependent diabetes mellitusSGLT-2 inhibitorUrine glucose excretion rate

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC